Surveys have shown that business leaders around the US are excited about Donald Trump’s return to the White House. But not all of the policies he’s promising appeal to every CEO. 

On today’s Big Take DC podcast, Business Roundtable CEO Josh Bolten joins host Saleha Mohsin to share what the business leaders he represents want from tax and trade policy — and Bloomberg’s Nancy Cook describes how Trump relishes one-on-one negotiations with fellow executives.

Read more: US Executives Turn More Optimistic After Trump Win, Surveys Show

Surveys have shown that business leaders around the US are excited about Donald Trump’s return to the White House. But not all of the policies he’s promising appeal to every CEO.  On today’s Big Take DC podcast, Business Roundtable CEO Josh Bolten joins host Saleha Mohsin to share what the business leaders he represents want from tax and trade policy — and Bloomberg’s Nancy Cook describes how Trump relishes one-on-one negotiations with fellow executives.
Read more: <a href="https://www.bloomberg.com/news/articles/2024-12-05/us-executives-turn-more-optimistic-after-trump-s-reelection-surveys-show">US Executives Turn More Optimistic After Trump Win, Surveys Show</a>

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

Big Take

We’re taking The Big Take to DC. Every Thursday, Bloomberg’s Saleha Mohsin digs into how money, politics, and power shapes Washington - and the consequences for voters across America.

We’re taking The Big Take to DC. Every Thursday, Bloomberg’s Saleha Mohsin digs into how money, politics, and power shapes Washington - and the consequences for voters across America.

Big Take DC

What CEOs Want From Trump

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ad363489-e293-4cd2-8589-b23e012b2b08/transcript

From inflation data to unemployment rates, the US government releases numbers every month that move markets and shape policies. But the agencies responsible for gathering that data are struggling — and President-elect Donald Trump’s promise to find cuts across agencies could further strain their resources.

On today’s Big Take DC podcast, Bloomberg economics editor Molly Smith joins host Saleha Mohsin to dig into what’s at stake if the federal government scales back on its investment in economic data.

Read more: 


Market-Moving Data Under Threat as Trump Returns to Washington
BLS Needs Culture Revamp After Botched US Releases, Review Finds

From inflation data to unemployment rates, the US government releases numbers every month that move markets and shape policies. But the agencies responsible for gathering that data are struggling &mdash; and President-elect Donald Trump&rsquo;s promise to find cuts across agencies could further strain their resources.
On today&rsquo;s Big Take DC podcast, Bloomberg economics editor Molly Smith joins host Saleha Mohsin to dig into what&rsquo;s at stake if the federal government scales back on its investment in economic data.
Read more:&nbsp;
<ul>
<li dir="ltr" aria-level="1">
<a href="https://www.bloomberg.com/news/articles/2024-12-11/market-moving-us-data-under-threat-as-trump-returns?srnd=undefined">Market-Moving Data Under Threat as Trump Returns to Washington</a>
</li>
<li dir="ltr" aria-level="1"><a href="https://www.bloomberg.com/news/articles/2024-12-10/bls-needs-culture-revamp-after-botched-us-releases-review-finds?sref=SFtCN2M4">BLS Needs Culture Revamp After Botched US Releases, Review Finds</a></li>
</ul>

Market-Moving US Economic Data Is Under Threat

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a24e4f76-f6e7-4263-b4bc-b2490156bc89/transcript

The gory, dystopian South Korean thriller Squid Game is the most popular series Netflix has ever released. This week, it drops season two — in the midst of the company’s efforts to grow the show beyond the screen.

On today’s Big Take Asia Podcast, host Rebecca Choong Wilkins talks to Bloomberg’s Sohee Kim and Lucas Shaw about the new season, the story of how the show was nearly never made and all the ways Netflix is trying to expand Squid Game into a global franchise — from reality TV and video games to in-person fan experiences. 


Read more: ‘Squid Game’ Returns in Test of Netflix Global Marketing Muscle

Further listening:K-Pop’s Big Bet on Becoming Less Korean

 

The gory, dystopian South Korean thriller Squid Game is the most popular series Netflix has ever released. This week, it drops season two &mdash; in the midst of the company&rsquo;s efforts to grow the show beyond the screen.
On today&rsquo;s Big Take Asia Podcast, host Rebecca Choong Wilkins talks to Bloomberg&rsquo;s Sohee Kim and Lucas Shaw about the new season, the story of how the show was nearly never made and all the ways Netflix is trying to expand Squid Game into a global franchise &mdash; from reality TV and video games to in-person fan experiences.&nbsp;
 Read more:&nbsp;<a href="https://www.bloomberg.com/news/articles/2024-11-14/netflix-squid-game-director-bet-on-season-2-to-supercharge-global-franchise?srnd=undefined">&lsquo;Squid Game&rsquo; Returns in Test of Netflix Global Marketing Muscle </a>Further listening: <a href="https://podcasts.apple.com/us/podcast/k-pops-big-bet-on-becoming-less-korean/id1746141911?i=1000663123261">K-Pop&rsquo;s Big Bet on Becoming Less Korean</a>
&nbsp;

Netflix’s Big Bet On ‘Squid Game’

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/369a2a9f-16f9-4190-a52f-b2500110ba24/transcript

Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That’s made them easier to access, but it’s also introduced new potential risks for people recovering from eating disorders like anorexia.

On today’s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she’s learned about the ways telehealth can make it easier for people to get prescriptions that could harm them.

Read more: The Weight-Loss Drug Gold Rush Has a Dangerous Prescription Problem

Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That&rsquo;s made them easier to access, but it&rsquo;s also introduced new potential risks for people recovering from eating disorders like anorexia.
On today&rsquo;s Big Take podcast, Bloomberg reporter Madison Muller joins host Sarah Holder to share what she&rsquo;s learned about the ways telehealth can make it easier for people to get prescriptions that could harm them.
Read more: <a href="https://www.bloomberg.com/news/features/2024-12-16/weight-loss-drugs-are-too-easily-prescribed-to-people-with-anorexia?srnd=undefined">The Weight-Loss Drug Gold Rush Has a Dangerous Prescription Problem</a>

The Weight-Loss Drug Boom’s Prescription Problem

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a27ac325-c1d2-4985-80d7-b24f0130c387/transcript

What CEOs Want From Trump

Big Take DC

In 2 playlist(s)

Big Take

Social links

Follow podcast

Recent clips